Cargando…

miRNA-92a inhibits vascular smooth muscle cell phenotypic modulation and may help prevent in-stent restenosis

The modulation of vascular smooth muscle cell (VSMC) phenotype during cellular proliferation and migration may represent a potential therapeutic approach for vascular intimal hyperplasia prevention. However, the precise role of this process in VSMC biology and remodeling remains unclear. In the pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Fenfen, Zhang, Bin, Zhang, Xiangyu, Zhang, Ran, Lu, Qin, Shi, Fengjie, Xu, Jianjiang, Deng, Lang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835053/ https://www.ncbi.nlm.nih.gov/pubmed/36601739 http://dx.doi.org/10.3892/mmr.2023.12927

Ejemplares similares

Plasma Small Extracellular Vesicle-Carried miRNA-501-5p Promotes Vascular Smooth Muscle Cell Phenotypic Modulation-Mediated In-Stent Restenosis
por: Gao, Xiao-Fei, et al.
Publicado: (2021)

Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation
por: McDonald, Robert A., et al.
Publicado: (2015)

Reducing Endogenous Labile Zn May Help to Reduce Smooth Muscle Cell Injury around Vascular Stents
por: Zeng, Zheng, et al.
Publicado: (2022)

Drug‐Eluting Stent Targeting Sp‐1‐Attenuated Restenosis by Engaging YAP‐Mediated Vascular Smooth Muscle Cell Phenotypic Modulation
por: Huang, Chen, et al.
Publicado: (2019)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
por: Zhao, Yinping, et al.
Publicado: (2020)

Long Non-Coding RNAs Might Regulate Phenotypic Switch of Vascular Smooth Muscle Cells Acting as ceRNA: Implications for In-Stent Restenosis
por: Arencibia, Alberto, et al.
Publicado: (2022)

Differential Expression of miRNA-223 in Coronary In-Stent Restenosis
por: Ganjali, Shiva, et al.
Publicado: (2022)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

Bioresorbable Vascular Scaffold Use in a Case of In-stent Restenosis
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2014)

lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells
por: Cao, Chen, et al.
Publicado: (2021)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP
por: Smith, Sarah A., et al.
Publicado: (2019)

Hif-1α/Slit2 Mediates Vascular Smooth Muscle Cell Phenotypic Changes in Restenosis of Bypass Grafts
por: Li, Sen, et al.
Publicado: (2023)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
por: Zhang, Kun, et al.
Publicado: (2021)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

Correlation between high perfusion syndrome and stent restenosis after stent implantation
por: Li, Yingyi, et al.
Publicado: (2016)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Effects of a Matrix Metalloproteinase Inhibitor-Eluting Stent on In-Stent Restenosis
por: Song, Jian-bo, et al.
Publicado: (2020)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy
por: Lompré, Anne-Marie, et al.
Publicado: (2013)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

Treatment of the Carotid In-stent Restenosis: A Systematic Review
por: Huang, Hao, et al.
Publicado: (2021)

Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis
por: Wang, Jinxuan, et al.
Publicado: (2018)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

Lin28a up‐regulation is associated with the formation of restenosis via promoting proliferation and migration of vascular smooth muscle cells
por: Zou, Zhiwei, et al.
Publicado: (2020)

Effects of the Vertebral Artery Ostium/Subclavian Artery Angle on In-Stent Restenosis after Vertebral Artery Ostium Stenting
por: Su, Hui, et al.
Publicado: (2021)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

In-stent restenosis and stented-territory infarction after carotid and vertebrobasilar artery stenting
por: Ryu, Jae-Chan, et al.
Publicado: (2023)

‘Miracle stents’ - a future without restenosis
por: Hamid, Huda, et al.
Publicado: (2007)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4f71vpoii26lrqj5a97c28434d